Nova Agritech Limited — Capital/Financing Update 2025

Jul 5, 2025

Registered Office: Sy.No.251/A/1., Singannaguda Village Mulugu Mandal, Medak, Siddipet - 502279, Telangana, India

==> picture [130 x 61] intentionally omitted <==

CIN : L01119TG2007PLC053901

+91 84 5425 3446 • cs@novaagri.in

5[th] July, 2025

To

BSE Limited , National Stock Exchange of India Limited , Listing Department, P J Towers, Listing Department, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544100 Trading Symbol: NOVAAGRI

SUB: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding commissioning of formulation plant set up using IPO proceeds.

Ref: Regulation 30 read with para “B” of part “A” of Schedule III of the SEBI (Listing Obligations &

Disclosure Requirements) Regulations, 2015.

Dear Sir/Madam,

With reference to the above-cited subject, we would like to inform you that pursuant to the objects stated in our Initial Public Offering (IPO) Prospectus dated 28[th] January, 2024, the formulation plants of the Company (“NATL”) and its Subsidiary (“NASPL”), established out of the IPO proceeds at Singannaguda Village, Mulugu Mandal, Siddipet District, Telangana, are now completed and ready for commissioning from 7[th] July 2025, marking the commencement of production.

The relevant objects as stated in the IPO prospectus are reproduced below for your reference:

Investment in our subsidiary, Nova Agri Sciences Private Limited (“NASPL”), for setting-up a new formulation plant	₹1420.11 lakh
Funding capital expenditure by our Company (“NATL”) towards expansion of our existing formulation plant	₹1048.95 lakhs

Page 1 of 3

The funds have been deployed strictly in accordance with the stated objects in the IPO prospectus, and the project has reached successful completion. We confirm that there is no material deviation or variation in the utilization of proceeds from the objects specified in the prospectus, as reported quarterly in Statement of Deviation submitted to the Exchanges.

The disclosures as required under SEBI Circular dated 11[th] November, 2024 are enclosed herewith as Annexure A . Please take the same on record and suitably disseminate it to all concerned.

Thanking you!

For Nova Agritech Limited

NEHA Digitally signed by NEHA SONI Date: 2025.07.05 SONI 14:01:18 +05'30'

Neha Soni

Company Secretary & Compliance Officer

Encls as above

Page 2 of 3

Annexure A

Inauguration and commissioning of formulation plant set up using IPO proceeds which tantamount to capacity addition:

(Pursuant to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11[th] November, 2024)

Particulars	Details
(a) Existing Capacity	NATL: 5928 MTPA NASPL: 3237.60 MTPA
(b) Existing Capacity Utilisation	NATL: 47.91% NASPL: 47.24% (as on 31st March, 2025)
(c) Proposed Capacity Addition	NATL: 8,664 MTPA NASPL: 10,032 MTPA
(d) Period within which the proposed capacity is to be added	The capacity is ready for commissioning from7th July 2025 onwards
(e) Investment Required	The following investment is made out of the IPO proceeds in accordance with Prospectus dated 28thJanuary, 2024: (i) Investment of₹1420.11 lakh was made in subsidiary company via OCD, for setting up of new formulation plant (ii) Investment of₹1048.95 lakhs is made towards expansion of our existing formulation plant The additional expenditure incurred were funded by respective companies from its internal accruals.
(f) Mode of Financing	Proceeds of IPO in accordance with Prospectus dated 28th January, 2024 and Internal Accruals
(g) Rationale	The new facilities will help us in increasing our competency level, making us self-sufficient in many ways across the entire manufacturing cycle of the product. The expansion of manufacturing capacity will leverage us to increase our visibility and secure future marketplace of Nova Agritech Limited products and Nova Agri Sciences Private Limited products by enhancing our production capacity.

Page 3 of 3